Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CFD | P00746 | 11/20 | 0.35 |
| ▸ | PSMB9 | P28065 | 1/20 | 0.33 |
| ▸ | ITGA4 | P13612 | 4/20 | 0.32 |
| ▸ | XIAP | P98170 | 3/20 | 0.31 |
| ▸ | BIRC3 | Q13489 | 3/20 | 0.31 |
| ▸ | BIRC2 | Q13490 | 3/20 | 0.31 |
| ▸ | BIRC8 | Q96P09 | 1/20 | 0.31 |
| ▸ | CTSS | P25774 | 1/20 | 0.31 |
| ▸ | CTSK | P43235 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24666675 | 1.00 | CFD (0.35) | CFDPSMB9ITGA4XIAPBIRC3 | |
| SCHEMBL30341359 | 1.00 | CFD (0.35) | CFDPSMB9ITGA4XIAPBIRC3 | |
| SCHEMBL29820367 | 1.00 | CFD (0.35) | CFDPSMB9ITGA4XIAPBIRC3 | |
| SCHEMBL30341411 | 0.93 | CFD (0.36) | CFDPSMB9ITGA4XIAPBIRC3 | |
| SCHEMBL24666741 | 0.93 | CFD (0.36) | CFDPSMB9ITGA4XIAPBIRC3 | |
| SCHEMBL29820726 | 0.93 | CFD (0.36) | CFDPSMB9ITGA4XIAPBIRC3 | |
| SCHEMBL29230735 | 0.93 | CFD (0.36) | CFDPSMB9ITGA4XIAPBIRC3 | |
| SCHEMBL24664545 | 0.89 | CFD (0.34) | CFDPSMB9ITGA4XIAPBIRC3 | |
| SCHEMBL24664536 | 0.89 | CFD (0.34) | CFDPSMB9ITGA4XIAPBIRC3 | |
| SCHEMBL30341435 | 0.89 | CFD (0.34) | CFDPSMB9ITGA4XIAPBIRC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117956985-A | Inhibitors of glycogen synthase 1 (GYS 1) and methods of use thereof | 梅兹治疗公司 | 2024-04-30 | — | — | CN | disclosed |